NBDF Announces a New Enduring and Accredited Educational Activity Available to Healthcare Providers
The National Bleeding Disorders Foundation (NBDF) is pleased to announce a new enduring and accredited educational activity available to healthcare providers. “Exploring Non-Factor Replacement Therapies for Hemophilia Care: Achieving Positive Outcomes,” was developed through a strategic collaboration between Medscape and The National Bleeding Disorders Foundation (NBDF) is pleased to announce a new enduring and accredited educational activity available to healthcare providers. “Exploring Non-Factor Replacement Therapies for Hemophilia Care: Achieving Positive Outcomes,” was developed through a strategic collaboration between Medscape and NBDF.
The National Bleeding Disorders Foundation (NBDF) is pleased to announce a new enduring and accredited educational activity available to healthcare providers. “Exploring Non-Factor Replacement Therapies for Hemophilia Care: Achieving Positive Outcomes,” was developed through a strategic collaboration between Medscape and NBDF.
It is intended for U.S.-based hematologist/oncologists, pediatricians, primary care physicians, emergency medicine physicians, nurses, pharmacists, and other members of the comprehensive hemophilia care team.
Participants who complete this activity will:
- Have increased knowledge regarding the
- Evidence supporting the development and use of non-factor replacement therapies for treatment of hemophilia
- Have greater competence related to
- Incorporating non-factor replacement therapies for the treatment of hemophilia
- Demonstrate greater confidence in their ability to
- Communicate with patients to design individualized care plans for incorporating non-factor replacement therapies into hemophilia treatment
Faculty
Stacy Croteau, MD, MMS
Medical Director
Boston Bleeding Disorders Center
Assistant Professor of Pediatrics
Harvard Medical School
Boston, Massachusetts
Regina Butler, RN-BC
Clinical Manager
Division of Hematology Nurse Coordinator
CHOP Hemostasis and Thrombosis Center
Philadelphia, Pennsylvania
To learn more about available credits and to register visit the program homepage.
This program is supported by an independent educational grant from Novo Nordisk.
Source: National Bleeding Disorders Foundation, September 2024